Latest news and publications Australia’s first sarcoidosis symposium amplifies patient voices and calls for urgent action The Sarcoidosis Advocacy and Research Initiative (SARI) at UNSW held Australia’s first Sarcoidosis Symposium on Saturday 1 20 May, 2026 Pulmonary sarcoidosis treatment efzofitimod Phase 3 trial to go on A global Phase 3 clinical trial evaluating efzofitimod 8 Jan, 2025 MRFF – Clinical Trials Activity Initiative - 2023 Clinical Trials Activity Grant Opportunity (GO6540) SARI has submitted a proposal for funding to: 5 Jun, 2024 Novel use of new hybrid PET/MRI imaging modality Hybrid Magnetic Resonance Positron Emission Tomography Is Associated With Cardiac-Related Outcomes in Cardiac Sarcoidosis. 6 Feb, 2024 Press Release: SARI – Sarcoidosis Advocacy and Research Initiative at UNSW Sydney Sarcoidosis is a little-known condition that may attack virtually every organ in the body, is very difficult to diagnose and 1 Dec, 2023 To read more, visit the Sarcoidosis news website Link Read more
Australia’s first sarcoidosis symposium amplifies patient voices and calls for urgent action The Sarcoidosis Advocacy and Research Initiative (SARI) at UNSW held Australia’s first Sarcoidosis Symposium on Saturday 1 20 May, 2026
Pulmonary sarcoidosis treatment efzofitimod Phase 3 trial to go on A global Phase 3 clinical trial evaluating efzofitimod 8 Jan, 2025
MRFF – Clinical Trials Activity Initiative - 2023 Clinical Trials Activity Grant Opportunity (GO6540) SARI has submitted a proposal for funding to: 5 Jun, 2024
Novel use of new hybrid PET/MRI imaging modality Hybrid Magnetic Resonance Positron Emission Tomography Is Associated With Cardiac-Related Outcomes in Cardiac Sarcoidosis. 6 Feb, 2024
Press Release: SARI – Sarcoidosis Advocacy and Research Initiative at UNSW Sydney Sarcoidosis is a little-known condition that may attack virtually every organ in the body, is very difficult to diagnose and 1 Dec, 2023
